BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 11218242)

  • 1. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease.
    Belaiche J; Desager JP; Horsmans Y; Louis E
    Scand J Gastroenterol; 2001 Jan; 36(1):71-6. PubMed ID: 11218242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of Concentrations of Azathioprine Metabolites 6-Thioguanine and 6-Methylmercaptopurine in Whole Blood With the Use of Liquid Chromatography Combined With Mass Spectrometry.
    Zochowska D; Zegarska J; Hryniewiecka E; Samborowska E; Jazwiec R; Tszyrsznic W; Borowiec A; Dadlez M; Paczek L
    Transplant Proc; 2016 Jun; 48(5):1836-9. PubMed ID: 27496503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients.
    Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM
    J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.
    Cuffari C; Théorêt Y; Latour S; Seidman G
    Gut; 1996 Sep; 39(3):401-6. PubMed ID: 8949645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
    Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
    Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring 6-thioguanine nucleotide concentrations in Japanese patients with inflammatory bowel disease.
    Andoh A; Tsujikawa T; Ban H; Hashimoto T; Bamba S; Ogawa A; Sasaki M; Saito Y; Fujiyama Y
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1373-7. PubMed ID: 18662197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
    Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.
    Derijks LJ; de Jong DJ; Gilissen LP; Engels LG; Hooymans PM; Jansen JB; Mulder CJ
    Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):63-7. PubMed ID: 12544696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease.
    Goldenberg BA; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 2004 Sep; 99(9):1744-8. PubMed ID: 15330913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of 6-thioguanine and 6-methylmercaptopurine metabolites in renal transplantation recipients and patients with glomerulonephritis treated with azathioprine.
    Chrzanowska M; Krzymański M
    Ther Drug Monit; 1999 Apr; 21(2):231-7. PubMed ID: 10217345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn's disease patients.
    Liu Q; Wang Y; Mei Q; Han W; Hu J; Hu N
    Scand J Gastroenterol; 2016 Sep; 51(9):1093-9. PubMed ID: 27152547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBC 6-TGN and hematological parameters in patients with Crohn's disease treated by azathioprine.
    D'Halluin PN; Tribut O; Branger B; Lebreton C; Bretagne JF; Bentue-Ferrer D; Heresbach D
    Gastroenterol Clin Biol; 2005 Dec; 29(12):1264-9. PubMed ID: 16518285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.
    Cuffari C; Dassopoulos T; Turnbough L; Thompson RE; Bayless TM
    Clin Gastroenterol Hepatol; 2004 May; 2(5):410-7. PubMed ID: 15118980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD.
    Spencer E; Norris E; Williams C; Dubinsky MC
    Inflamm Bowel Dis; 2019 Jan; 25(1):142-149. PubMed ID: 29920603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved methods for determining the concentration of 6-thioguanine nucleotides and 6-methylmercaptopurine nucleotides in blood.
    Pike MG; Franklin CL; Mays DC; Lipsky JJ; Lowry PW; Sandborn WJ
    J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(1):1-9. PubMed ID: 11419732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.
    Dassopoulos T; Dubinsky MC; Bentsen JL; Martin CF; Galanko JA; Seidman EG; Sandler RS; Hanauer SB
    Aliment Pharmacol Ther; 2014 Jan; 39(2):163-75. PubMed ID: 24237037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
    Bonaz B; Boitard J; Marteau P; Lémann M; Coffin B; Flourié B; Belaiche J; Cadiot G; Metman EH; Cortot A; Colombel JF;
    Aliment Pharmacol Ther; 2003 Aug; 18(4):401-8. PubMed ID: 12940925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mercaptopurine metabolite results in clinical gastroenterology practice.
    Bloomfeld RS; Onken JE
    Aliment Pharmacol Ther; 2003 Jan; 17(1):69-73. PubMed ID: 12492734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
    Barnes BH; Borowitz SM; Saulsbury FT; Hellems M; Sutphen JL
    J Pediatr Gastroenterol Nutr; 2004 May; 38(5):509-12. PubMed ID: 15097439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.
    Reinshagen M; Schütz E; Armstrong VW; Behrens C; von Tirpitz C; Stallmach A; Herfarth H; Stein J; Bias P; Adler G; Shipkova M; Kruis W; Oellerich M; von Ahsen N
    Clin Chem; 2007 Jul; 53(7):1306-14. PubMed ID: 17495015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.